Valuation: Rohto Pharmaceutical Co.,Ltd.

Market Cap 648B 4.08B 3.49B 3.26B 2.99B 5.62B 390B 5.73B 38.67B 15.08B 196B 15.32B 14.99B P/E 2027 *
18.5x
P/E 2028 * 17.3x
Enterprise Value 587B 3.69B 3.16B 2.95B 2.71B 5.09B 353B 5.19B 35.01B 13.65B 177B 13.87B 13.57B EV / Sales 2027 *
1.58x
EV / Sales 2028 * 1.47x
Free-Float
84.69%
Yield 2027 *
1.74%
Yield 2028 * 1.8%
1 day-0.02%
1 week+1.81%
Current month+20.01%
1 month+17.72%
3 months+13.93%
6 months+21.56%
Current year+9.08%
1 week 2,725.5
Extreme 2725.5
2,901.5
1 month 2,285
Extreme 2285
2,918.5
Current year 2,218.5
Extreme 2218.5
2,918.5
1 year 2,218.5
Extreme 2218.5
2,918.5
3 years 1,964.5
Extreme 1964.5
4,117
5 years 1,515
Extreme 1515
4,117
10 years 762
Extreme 762
4,117
Manager TitleAgeSince
Chief Executive Officer 70 2019-05-31
President 64 2025-06-25
Director of Finance/CFO 62 2022-02-28
Director TitleAgeSince
Chairman 70 2009-05-31
Director/Board Member 70 2010-05-31
Director/Board Member 62 2011-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.02%+1.81%+13.82%-21.21% 4.08B
-2.81%+2.93%+76.40%+127.73% 1,109B
-2.21%+2.02%+49.50%+55.01% 644B
-1.56%+4.39%+25.19%+74.39% 463B
+1.20%+2.62%+41.69%+45.78% 371B
-0.61%+2.10%+23.43%+41.34% 301B
+0.32%+3.25%+0.94%+13.42% 256B
-1.95%+3.80%+46.31%+65.66% 234B
-1.10%-0.70%-14.31%-52.66% 205B
-2.82%+3.84%+20.81%+89.04% 178B
Average -1.16%+2.80%+28.38%+43.85% 376.51B
Weighted average by Cap. -1.62%+3.25%+43.22%+70.32%

Financials

2027 *2028 *
Net sales 371B 2.34B 2B 1.87B 1.71B 3.22B 224B 3.28B 22.15B 8.63B 112B 8.78B 8.59B 385B 2.43B 2.08B 1.94B 1.78B 3.34B 232B 3.41B 23B 8.97B 116B 9.11B 8.92B
Net income 35.02B 221M 189M 176M 162M 304M 21.11B 310M 2.09B 815M 10.58B 828M 810M 37.47B 236M 202M 189M 173M 325M 22.58B 332M 2.24B 872M 11.32B 886M 867M
Net Debt -61.32B -386M -331M -309M -283M -532M -36.96B -543M -3.66B -1.43B -18.52B -1.45B -1.42B -80.92B -510M -436M -407M -374M -702M -48.77B -716M -4.83B -1.88B -24.44B -1.91B -1.87B
Logo Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of eye care (eye drops, eyewash), skin care (external medications, lip balm, sunscreen, functional cosmetics), oral medication (gastrointestinal medicines, herbal medicines, supplements), and other products and services (in vitro diagnostic reagents) in the health and beauty care field. The Company operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).
Employees
9,292
Date Price Change Volume
26-08-21 JP¥2,866.50 -0.02% 1,044,000
26-08-20 JP¥2,867.00 +2.21% 1,096,500
26-08-19 JP¥2,805.00 +1.25% 1,014,100
26-08-18 JP¥2,770.50 +0.75% 672,700
26-08-17 JP¥2,750.00 -2.33% 779,900
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
2,867.00JPY
Average target price
2,975.45JPY
Spread / Average Target
+3.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4527 Stock